Here Are 9 Stocks to Consider. To view this site properly, enable cookies in your browser. The increasing cases of hormone-related disorders in both men and women of different age groups will spur demand for hormone replacement therapy, which in turn, will boost the hormone replacement therapy market growth during the forecast period. Should you invest in Exxon Mobil, Ultragenyx Pharmaceutical, Arch Resources, AbbVie, or Alibaba? Why That’s the ‘Near-Worst-Case Scenario’ for Gilead Stock. Takes you to an interactive chart which cannot interact. 351 King Street East, Suite 1600, Toronto, ON Canada, M5A 0N1, Unchecking box will stop auto data updates. These 14 Are Cheap and Could Grow. The current stock performance of AbbVie shows a 52-week-high of 101.28 and a 52-week-low of 62.55. A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. Available for free with registration. For subscribers only. Read our. Get today's AbbVie Inc stock price and latest ABBV news as well as AbbVie real-time stock quotes, technical analysis, full financials and more. - PR Newswire - PRF - Fri Oct 30, 9:45AM CDT. Copyright 2020© FactSet Research Systems Inc. All rights reserved. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. * With a current rating of Buy, Truist Securities initiated coverage on AbbVie Inc (NYSE: ABBV). Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Copyright 2020 FactSet Research Systems Inc. All rights reserved. Fundamental company data and analyst estimates provided by FactSet. Kyle Dennis took a leap of faith and decided to invest his savings of $15K in the stock market — $2.8M later, he owes his success to these strategies. © 2020 Verizon Media. All rights reserved. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2020© Refinitiv. Cannabis Use Is on the Rise. AbbVie Reports Third-Quarter 2020 Financial Results, AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ(TM) (upadacitinib) in Atopic Dermatitis, AbbVie Highlights Innovative Research for People with Rheumatic Diseases with New Data at ACR Convergence 2020, Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia, AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ(TM) (upadacitinib) in Atopic Dermatitis, AbbVie Announces Commencement of Registered Exchange Offers, VENCLEXTA(R) (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia (AML), Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting, Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business, AbbVie to Host Third-Quarter 2020 Earnings Conference Call, ABBV LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against AbbVie Inc. and Encourages Investors with Losses to Contact the Firm, AbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International Symposium, Public coverage of AbbVie's SKYRIZI® for the treatment of Moderate to Severe Plaque Psoriasis is now available across additional jurisdictions, AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury, Malin Akerman Joins CoolSculpting(R) and CoolTone(TM) as U.S. © Copyright 2020 The Globe and Mail Inc. All rights reserved. Since then, ABBV stock has increased by 0.3% and is now trading at $85.10. AbbVie is a global, research-based biopharmaceutical company. In addition, the increasing prevalence of disorders such as growth deficiency, thyroid disorders, and others will create new sales opportunities for the market in the forthcoming years. History. AbbVie earned $2.34 in the second quarter, compared to $2.26 in the year-ago quarter. 9 Dividend Stocks That Can Help Anyone Looking for Income. Detailed price information for Abbvie Inc (ABBV-N) from The Globe and Mail including charting and trades. Gilead Stock Is Rising Because Covid-Treatment Sales Could Top $3 Billion, Coronavirus update: U.S. counts almost 100,000 cases in new one-day record; The Lancet says Trump pandemic response is ‘disastrous’, Moderna Inc. stock falls Friday, underperforms market, AbbVie Logs 3Q Sales Growth on Higher Immunology, Oncology Results, Moderna Inc. stock rises Thursday, outperforms market, Vertex Pharmaceuticals Inc. stock falls Wednesday, still outperforms market, AbbVie Inc. stock outperforms market despite losses on the day, Moderna Inc. stock falls Wednesday, underperforms market, Allergan Presbyopia Treatment Hits Main Endpoint in Phase 3 Studies, Plug Power Inc. stock outperforms competitors on strong trading day, Biogen Inc. stock outperforms competitors despite losses on the day, Gilead Sciences Inc. stock rises Tuesday, outperforms market, Moderna Inc. stock rises Tuesday, still underperforms market, Vertex Pharmaceuticals Inc. stock rises Tuesday, outperforms market, Moderna Inc. stock falls Monday, still outperforms market, Moderna Inc. stock underperforms Friday when compared to competitors, Moderna Inc. stock underperforms Wednesday when compared to competitors, Moderna Inc. stock outperforms market on strong trading day, Moderna Inc. stock falls Monday, underperforms market, AbbVie Seeks U.S., European OK of Rinvoq in Eczema. AbbVie's stock was trading at $84.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Ambassador for the Allergan Aesthetics Body Contouring Portfolio, Allergan Aesthetics and Skinbetter Science Announce The DREAM Initiative(TM) To Advance Health Equity and Diversity in Aesthetics, AbbVie to Present New Data From 18 Abstracts at the International Congress of Parkinson's Disease and Movement Disorders(R), AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy, Vanguard US Total Market Shares Index ETF, Spdr Series - Health Care Select Sector Spdr Fund, Capital Research & Management Co. (Global Investors), T. Rowe Price Associates, Inc. (Investment Management), Northern Trust Investments, Inc.(Investment Management).